This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Laboratory Corporation of America Holdings, Sequenom, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Chen Xu
Introduction
Chen Xu is a notable inventor based in San Diego, California. He has made significant contributions to the field of medical technology, particularly in the area of transplant rejection detection. His work is vital for improving patient outcomes in organ transplantation.
Latest Patents
Chen Xu holds a patent titled "Methods and Systems to Detect Transplant Rejection." This innovative approach aims to enhance the accuracy and efficiency of detecting organ transplant rejection, which is crucial for patient care.
Career Highlights
Currently, Chen Xu is employed at Sequenom, Inc., a company known for its advancements in genetic testing and diagnostics. His role at Sequenom allows him to apply his expertise in developing cutting-edge technologies that address critical healthcare challenges.
Collaborations
Throughout his career, Chen has collaborated with esteemed colleagues such as Roy Brian Lefkowitz and John Allen Tynan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Chen Xu's contributions to the field of transplant rejection detection exemplify the impact of innovative thinking in healthcare. His work continues to pave the way for advancements that can significantly improve patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile